Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minyu Chen

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Translational Andrology and Urology|April 10, 2023
Development and validation of a novel defined mutation classifier based on Lasso logistic regression for predicting the overall survival of immune checkpoint inhibitor therapy in renal cell carcinomaMinyu Chen, Pengju Li, Haohua Yao, et al.
Cancer Medicine|March 13, 2024
A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinomaPengju Li, Quanhui Xu, Minyu Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 29, 2026
Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 PathwaysJinchen Luo, Hansen Lin, Haoqian Feng, et al.
ACS Photonics|October 21, 2024
Approaches for Positioning the Active Medium in Hybrid Nanoplasmonics. Focus on Plasmon-Assisted PhotopolymerizationMinyu Chen, Sylvie Marguet, Ali Issa, et al.
Frontiers in Immunology|August 8, 2025
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapyWuyuan Liao, Xinwei Zhou, Hansen Lin, et al.
Cell Proliferation|May 16, 2025
Deciphering the Immunomodulatory Function of GSN<sup>+</sup> Inflammatory Cancer-Associated Fibroblasts in Renal Cell Carcinoma Immunotherapy: Insights From Pan-Cancer Single-Cell Landscape and Spatial Transcriptomics AnalysisShan Li, Xinwei Zhou, Haoqian Feng, et al.
Cancer Research|February 21, 2024
PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell CarcinomaGuannan Shu, Minyu Chen, Wuyuan Liao, et al.
Journal of Translational Medicine|May 24, 2023
Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinomaHansen Lin, Liangmin Fu, Pengju Li, et al.
Annals of Medicine|August 27, 2024
Exploring and identifying the imaging biomarkers for predicting anti-VEGF treatment response in polypoidal choroidal vasculopathy: a prospective multicenter studyWenfei Zhang, Xingwang Gu, Bing Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 13, 2023
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1Yihui Pan, Guannan Shu, Liangmin Fu, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Translational Andrology and Urology|April 10, 2023
Development and validation of a novel defined mutation classifier based on Lasso logistic regression for predicting the overall survival of immune checkpoint inhibitor therapy in renal cell carcinomaMinyu Chen, Pengju Li, Haohua Yao, et al.
Cancer Medicine|March 13, 2024
A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinomaPengju Li, Quanhui Xu, Minyu Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 29, 2026
Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 PathwaysJinchen Luo, Hansen Lin, Haoqian Feng, et al.
ACS Photonics|October 21, 2024
Approaches for Positioning the Active Medium in Hybrid Nanoplasmonics. Focus on Plasmon-Assisted PhotopolymerizationMinyu Chen, Sylvie Marguet, Ali Issa, et al.
Frontiers in Immunology|August 8, 2025
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapyWuyuan Liao, Xinwei Zhou, Hansen Lin, et al.
Cell Proliferation|May 16, 2025
Deciphering the Immunomodulatory Function of GSN<sup>+</sup> Inflammatory Cancer-Associated Fibroblasts in Renal Cell Carcinoma Immunotherapy: Insights From Pan-Cancer Single-Cell Landscape and Spatial Transcriptomics AnalysisShan Li, Xinwei Zhou, Haoqian Feng, et al.
Cancer Research|February 21, 2024
PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell CarcinomaGuannan Shu, Minyu Chen, Wuyuan Liao, et al.
Journal of Translational Medicine|May 24, 2023
Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinomaHansen Lin, Liangmin Fu, Pengju Li, et al.
Annals of Medicine|August 27, 2024
Exploring and identifying the imaging biomarkers for predicting anti-VEGF treatment response in polypoidal choroidal vasculopathy: a prospective multicenter studyWenfei Zhang, Xingwang Gu, Bing Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 13, 2023
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1Yihui Pan, Guannan Shu, Liangmin Fu, et al.
Pageof 5